Predict your next investment

HEALTHCARE | Biotechnology
humacyte.com

See what CB Insights has to offer

Total Raised

$438.81M

Investors Count

12

Deal Terms

3

Humacyte Funding, Humacyte Valuation & Humacyte Revenue

9 Fundings

Humacyte's latest funding round was a Corporate Minority - P2P for $25M on August 30, 2021.

Humacyte's valuation in February 2021 was $800 - $1,100M.

Humacyte's latest post-money valuation is from February 2021.

Sign up for a free trial to see Humacyte's valuations in June 2018 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/30/2021

Corporate Minority - P2P

$25M

5

2/17/2021

Reverse Merger

$800 - $1,100M

10

4/27/2020

Loan

$99M

0

6/11/2018

Corporate Minority

$99M

$99M

10

3/9/2018

Series C

$99M

10

Date

8/30/2021

2/17/2021

4/27/2020

6/11/2018

3/9/2018

Round

Corporate Minority - P2P

Reverse Merger

Loan

Corporate Minority

Series C

Amount

$25M

$99M

$99M

$99M

Investors

Valuation

$800 - $1,100M

$99M

Revenue

Sources

5

10

0

10

10

Humacyte Deal Terms

3 Deal Terms

Humacyte's deal structure is available for 3 funding rounds, including their Reverse Merger from February 17, 2021.

Round

Reverse Merger

Corporate Minority

Series B

Funding Date

$99M

$99M

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Reverse Merger

$99M

$99M

$99M

$99M

Corporate Minority

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

Humacyte Investors

12 Investors

Humacyte has 12 investors. Fresenius Medical Care invested in Humacyte's Corporate Minority - P2P funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/11/2018

8/30/2021

2
Corporate Minority, Corporate Minority - P2P (2021)

Corporation

Germany

2/17/2021

2/17/2021

1
Reverse Merger

SPAC

New York

4/27/2020

4/27/2020

1
Loan

Government

DC

00/00/0000

00/00/0000

PointState Capital

Subscribe to see more

Asset/Investment Management

New York

00/00/0000

00/00/0000

Medical Technology Enterprise Consortium

Subscribe to see more

Public-Private Partnership

United States

First funding

6/11/2018

2/17/2021

4/27/2020

00/00/0000

00/00/0000

Last Funding

8/30/2021

2/17/2021

4/27/2020

00/00/0000

00/00/0000

Investor

PointState Capital

Medical Technology Enterprise Consortium

Rounds

2
Corporate Minority, Corporate Minority - P2P (2021)
1
Reverse Merger
1
Loan

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

SPAC

Government

Asset/Investment Management

Public-Private Partnership

Location

Germany

New York

DC

New York

United States

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.